Login to Your Account

Early Stage Deals Still Wow? Innate Jumps on BMS Alliance

By Jennifer Boggs

Friday, July 8, 2011
During last week's BIO International Convention in Washington, panelists in a business development session discussed whether biotech firms can count on scoring major dollars by licensing early stage – preclinical or Phase I – programs.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription